1. Home
  2. FAF vs GRFS Comparison

FAF vs GRFS Comparison

Compare FAF & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FAF
  • GRFS
  • Stock Information
  • Founded
  • FAF 1889
  • GRFS 1940
  • Country
  • FAF United States
  • GRFS Spain
  • Employees
  • FAF N/A
  • GRFS N/A
  • Industry
  • FAF Specialty Insurers
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FAF Finance
  • GRFS Health Care
  • Exchange
  • FAF Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • FAF 6.1B
  • GRFS 7.2B
  • IPO Year
  • FAF N/A
  • GRFS 2006
  • Fundamental
  • Price
  • FAF $66.48
  • GRFS $10.16
  • Analyst Decision
  • FAF Buy
  • GRFS Hold
  • Analyst Count
  • FAF 4
  • GRFS 1
  • Target Price
  • FAF $75.00
  • GRFS $10.30
  • AVG Volume (30 Days)
  • FAF 650.2K
  • GRFS 1.2M
  • Earning Date
  • FAF 07-23-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • FAF 3.34%
  • GRFS 1.41%
  • EPS Growth
  • FAF N/A
  • GRFS 132.60
  • EPS
  • FAF 1.82
  • GRFS 0.53
  • Revenue
  • FAF $6,514,800,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • FAF $17.05
  • GRFS $5.40
  • Revenue Next Year
  • FAF $9.20
  • GRFS $6.74
  • P/E Ratio
  • FAF $35.61
  • GRFS $25.30
  • Revenue Growth
  • FAF 9.54
  • GRFS 9.32
  • 52 Week Low
  • FAF $53.09
  • GRFS $6.19
  • 52 Week High
  • FAF $70.92
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • FAF 69.24
  • GRFS 47.68
  • Support Level
  • FAF $64.18
  • GRFS $10.06
  • Resistance Level
  • FAF $65.27
  • GRFS $10.84
  • Average True Range (ATR)
  • FAF 1.11
  • GRFS 0.24
  • MACD
  • FAF 0.15
  • GRFS -0.12
  • Stochastic Oscillator
  • FAF 89.70
  • GRFS 12.82

About FAF First American Corporation (New)

First American Financial Corp is a financial services business providing insurance through segments: Title insurance and related services segment include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services; The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period; and The corporate segment includes investments in venture-stage companies, certain financing facilities and corporate services supporting the company's business operations.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: